Navigation Links
Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain

A new study in Japan has found migraine medication sumatriptan, known by the brand names Imitrex or Imigran, can provide relief for pain// due to trigeminal neuralgia up to eight hours.

Now researchers have found that a migraine medication could provide relief for people who suffer from, trigeminal neuralgia. Researchers had injected the drug and found it produced rapid and significant pain relief without serious adverse reactions.

Pain experienced with trigeminal neuralgia that affects the nerves in the face, sometimes known as tic douloureux, comes in lightning-like stabs that radiate from the angle of the jaw to the front of the face. The shocks are momentary but can repeat for several seconds. Paroxysms may last for hours, and then subside for long periods. This pain is often considered as one of the severest pains. Compression of the root of the trigeminal nerves by an artery is thought to cause trigeminal neuralgia.

Dr Akifumi Kanai and colleagues from Kitasato University School of Medicine explained this in the journal of Headache. The team led by Dr Kanai's examined the possible effectiveness of a subcutaneous injection of sumatriptan compared with saline in the treatment of trigeminal neuralgia in 24 patients. According to investigators, it was found to significantly decrease pain scores on a 0-10 scale from 8.3 to 2.4, according to the investigators. Pain scores did not change with placebo injection. Twenty patients described their pain as moderately or slightly better after sumatriptan treatment as compared with only one patient after being injected with saline injection. The analgesic effect of sumatriptan lasted for 1 to 20 hours, averaging 7.9 hours overall.

Dr Julio Pascual of University Hospital in Salamanca, Spain, in his editorial explained that the rapid onset of relief is plus, but subcutaneous injections that should be given at least twice a day would be a drawback. He went to suggest that sumatrip
'"/>




Page: 1 2

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study Finds That Migraine Drug Can Ease The Severest Facial Pain

(Date:5/27/2015)... One of America's most cherished actors, James Earl ... that takes a look at the topic of atrial ... abnormal heart rhythm. Those who suffer from atrial fibrillation ... too quickly. , This new segment will take a ... to inform viewers about possible signs that commonly indicate ...
(Date:5/27/2015)... 27, 2015 The Academy of Oncology ... Coast Regional Meeting in Seattle. This intimate gathering, held ... 200 navigation and oncology professionals from west of the ... , “One of the most important things that an ... their needs and do the best it can to ...
(Date:5/26/2015)... 27, 2015 Carey Danis & ... testosterone gel lawsuit . The suit pertains to AndroGel, ... was filed in late April 2015, and a court ... Illinois federal court in mid-May.¹ , Testosterone gel lawsuits ... the Northern District of Illinois. The multidistrict litigation (MDL) ...
(Date:5/26/2015)... Readers who struggle with memory , ... Chester Litvin ’s new book, “ Introduction to ... Trafford Publishing). , Litvin, who is a clinical psychologist, ... This book will guide readers through a series of ... cells . He shares his patented process for reviving ...
(Date:5/26/2015)... Liverpool, Ohio (PRWEB) May 26, 2015 Mr. ... role since 2010, will start working together this week to ... an accomplished career in healthcare executive leadership and strategy. ... CEO prior to the hiring of Mr. Cochran. The Board ... skills will complement the improvement strategies implemented over the past ...
Breaking Medicine News(10 mins):Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 2Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 3Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3
... Harvard Medical School, of more than 100,000 women, indicates ... either psychiatric// illnesses or other conditions, may have an ... about 52,000 women who were taking dopamine antagonists and ... compared for breast cancer rates. It was found that ...
... of Nature Medicine by researchers in Rene Descartes University has ... vaccine which may one day let people quit their AIDS ... promising results, and if confirmed and adapted in humans may ... researchers reported that the new vaccine uses a type of ...
... age people are now increasingly taking to gardening as a ... of beautiful gardens. Though gardening has been proven to have ... gardeners who start with little or no idea of how ... up having severe back pain. ,A recent study of ...
... published in the British Medical Journal suggests that there is ... of their offspring. In contrast to overweight children given birth ... are likely to weigh less than other children. ... 186 grams less than other children and this significant difference ...
... ancient Chinese medical practices that has gained widespread ... suggest that along with other therapies, the traditional ... paediatric patients. ,A recent study which shows ... to acupuncturists, proves the popularity of the traditional ...
... Dietary Supplements & Diabetes ,A recent ... conducted by Dr.Vijay Jayagopal and his colleagues from the ... understand the benefits of dietary supplements on type 2 ... menopausal women with type 2 diabetes who //either received ...
Cached Medicine News:Health News:A Compilation of recent Diabetes Research articles 2
(Date:5/26/2015)... 2015 /CNW/ - Export Development Canada (EDC) today announced a ... Montreal,s Valeant Pharmaceuticals International, Inc. (Valeant), ... The loan is part of a ... is using to fund the repayment of certain outstanding ... pharmaceutical company based in the US. Salix was acquired ...
(Date:5/26/2015)... 26, 2015  Haemonetics Corporation (NYSE: HAE ) ... Investor Relations, will present at The East Coast IDEAS ... June 4 th , 2015 at 2:30pm Eastern time.  ... presentation live via webcast at: http://www.wsw.com/webcast/threepa16/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/26/2015)... May 26, 2015  Amgen (NASDAQ: AMGN ) ... Phase 3 OPTiM study in the Journal of ... data published in JCO , which were previously ... of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated ... with unresected stage IIIB, IIIC or IV metastatic melanoma ...
Breaking Medicine Technology:EDC provides Valeant Pharmaceuticals with USD 67.5 M to support recent Salix Pharmaceuticals acquisition 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8
... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... products for central nervous system disorders, today announced it will ... May 5, 2011, before the market opens. A full text ... Mihael H. Polymeropoulos, M.D., President and Chief Executive ...
... NEW BRAUNFELS, Texas, April 22, 2011 One hundred and ... challenge bike riders in the BP MS 150 overcame on ... Sclerosis. Team Freedom, a corporate team sponsored by The ... solutions and services, completed the two-day ride and raised nearly ...
Cached Medicine Technology:Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011 2The SCOOTER Store Supports Fight Against Multiple Sclerosis 2
... the best of both worlds, the ... is the latest addition to the ... bipolar cautery instruments for ophthalmic surgery. ... extrusion aspiration and backflush functionality in ...
...
...
...
Medicine Products: